4.7 Article

KPC-2 carbapenemase-producing Pseudomonas aeruginosa reaching Germany

Journal

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 73, Issue 7, Pages 1812-1814

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/jac/dky105

Keywords

-

Funding

  1. Robert Koch Institute
  2. German Ministry of Health [1369-402]

Ask authors/readers for more resources

Background: Antimicrobial resistance due to carbapenemase expression poses a worldwide threat in health-care. Inter-genus exchange of genetic information is of utmost importance in this context. Objectives: Here, to the best of our knowledge, we describe the first detection and characterization of a KPC-2-producing Pseudomonas aeruginosa in Germany. Methods: Characterization of the isolate was performed using MALDI-TOF MS, automated microdilution and MLST. Carbapenemase detection was performed using phenotypic and genotypic assays. The bla(KPC-2)-carrying plasmid was transformed into Escherichia coli NEB VR 10-beta. The purified plasmid DNA was sequenced using the Illumina technique. Results: The isolate expressed ST235 and was resistant to carbapenems. Antimicrobial susceptibility testing revealed colistin to be the only antimicrobial agent active in vitro. The bla(KPC-2) gene was located on a replicon type lncHI1 plasmid as part of Tn4401. Conclusions: The first detection (to the best of our knowledge) of plasmid-encoded KPC-2 in P. aeruginosa in Germany may point to a currently underestimated spread of carbapenemases among clinically relevant Gram-negative bacteria. Here, to the best of our knowledge, we also provide the first report of bla(KPC-2) associated with the IncHI1 plasmid.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available